Abiopharma

Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration

SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology

Innovative Eyewear, Inc. Announces Record-Breaking 65% Annual Sales Growth in 2025 & Insider Buying Intent

AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

4DMT Provides Company Update and Anticipated Development Milestones for 2026

SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director

Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026

Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts

Alterity Therapeutics Limited (ATHE) Files Form 6-K

Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™

BRAINSWAY (BWAY) Files Form 6-K

TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference